DocSym
β
Searchsearch
Search
(E16.3) Increased secretion of glucagon
More details coming soon
971 353 in individuals diagnosis increased secretion of glucagon confirmed
11 016 deaths with diagnosis increased secretion of glucagon
1% mortality rate associated with the disease increased secretion of glucagon
Diagnosis increased secretion of glucagon is diagnosed Women are 10.75% more likely than Men
433 457
Men receive the diagnosis increased secretion of glucagon
4 515 (1.0 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
537 896
Women receive the diagnosis increased secretion of glucagon
6 501 (1.2 %)Died from this diagnosis.
Risk Group for the Disease increased secretion of glucagon - Men aged 75-79 and Women aged 80-84
In Men diagnosis is most often set at age 0-95+
in in men, the disease manifests at any agein in women, the disease manifests at any age
In Women diagnosis is most often set at age 0-95+
Disease Features increased secretion of glucagon
Absence or low individual and public risk
Increased secretion of glucagon - what does this mean
Increased secretion of glucagon occurs when the pancreas fails to produce enough insulin, which is essential for regulating blood sugar levels. as a result, glucagon levels increase in an attempt to stimulate the release of glucose from the liver and raise blood glucose levels.
What happens during the disease - increased secretion of glucagon
Increased secretion of glucagon is a condition in which the body produces too much glucagon, a hormone that helps regulate blood sugar levels. this can lead to an increase in blood sugar levels, which can cause symptoms such as increased thirst, frequent urination, fatigue, blurred vision, and weight loss. long-term complications can include nerve damage, kidney damage, and eye damage. treatment typically involves medications to control blood sugar levels and lifestyle changes to help manage the condition.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Physical examination
- Blood tests
- Urine tests
- Imaging tests such as X-rays, CT scans, or MRI scans
- Endoscopic procedures such as endoscopic ultrasound or endoscopic retrograde cholangiopancreatography (ERCP)
- Genetic testing
- Glucagon stimulation test
Treatment and Medical Assistance
Main Goal: Reduce the secretion of glucagon
- Prescribe medications that reduce glucagon secretion, such as metformin, sulfonylureas, and thiazolidinediones.
- Suggest lifestyle modifications, such as regular exercise, healthy eating, and weight loss.
- Recommend supplements that can help reduce glucagon secretion, such as chromium, magnesium, and omega-3 fatty acids.
- Advise patients to reduce their intake of refined carbohydrates and sugar.
- Prescribe insulin injections, if necessary.
12 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Increased secretion of glucagon - Prevention
The prevention of increased secretion of glucagon can be achieved by maintaining a healthy lifestyle, including regular physical activity, a balanced diet, and avoiding smoking and excessive alcohol consumption. additionally, it is important to manage any underlying medical conditions that may lead to increased glucagon secretion, such as diabetes or obesity.